Farther Finance Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$104K Buy
1,914
+348
+22% +$15.6K ﹤0.01% 2824
2026
Q2
$65.9K Buy
1,566
+727
+87% +$23.2K ﹤0.01% 3031
2026
Q1
$22.7K Sell
839
-100
-11% -$2.93K ﹤0.01% 3569
2025
Q4
$27.2K Buy
939
+9
+1% +$270 ﹤0.01% 3226
2025
Q3
$25.8K Buy
930
+265
+40% +$6.7K ﹤0.01% 2864
2025
Q2
$16.2K Sell
665
-34
-5% -$745 ﹤0.01% 2806
2025
Q1
$14.1K Buy
699
+409
+141% +$10.3K ﹤0.01% 2562
2024
Q4
$6.83K Sell
290
-10,360
-97% -$255K ﹤0.01% 2536
2024
Q3
$273K Sell
10,650
-222
-2% -$5.65K 0.01% 870
2024
Q2
$253K Buy
10,872
+1,481
+16% +$37.4K 0.01% 738
2024
Q1
$266K Buy
9,391
+2,783
+42% +$83.7K 0.02% 589
2023
Q4
$217K Buy
6,608
+4,680
+243% +$127K 0.02% 531
2023
Q3
$53.7K Hold
1,928
– – 0.01% 751
2023
Q2
$65.7K Hold
1,928
– – 0.01% 581
2023
Q1
$58K Hold
1,928
– – 0.02% 569
2022
Q4
$54.4K Buy
+1,928
New +$61.2K 0.02% 467

Other funds holding ARKG

Farther Finance Advisors's ARKG Position: Q3 2026 in Review

Farther Finance Advisors increased its ARK Genomic Revolution ETF (ARKG) stake by 22% in Q3 2026, buying an estimated $15.6K and bringing the position to 1,914 shares worth $104K. The position accounts for ﹤0.01% of the portfolio, ranked #2824.

Farther Finance Advisors first reported a position in ARKG in Q4 2022 and has held it in 16 quarters since. The position peaked at $273K in Q3 2024. 8 funds tracked by Wall St. Rank hold ARKG as of Q3 2026.

  • Farther Finance Advisors held 1,914 shares of ARK Genomic Revolution ETF worth $104K as of Q3 2026.
  • Farther Finance Advisors bought 348 ARK Genomic Revolution ETF shares in Q3 2026, an estimated $15.6K.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #2824 holding.
  • Farther Finance Advisors first reported a position in ARK Genomic Revolution ETF in Q4 2022 and has held it in 16 quarters since.
  • Farther Finance Advisors's ARK Genomic Revolution ETF position peaked at $273K in Q3 2024.
  • 8 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.